Clinical Trial

Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma

Name: Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma — clinical trial record (NCT07093073)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a single-arm, open-label clinical study evaluating the efficacy and safety of U01 (ssCART-19) in patients with relapsed or refractory B-cell lymphoma.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2025-07-28; most recent amendment 2026-04-29.

Trial Details

NCT Number	NCT07093073
Lead Sponsor	Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Conditions	B Cell Lymphoma
Enrollment	30 participants
Start Date	2025-01-23
Primary Completion	2027-01-31 (estimated)
Study Completion	2029-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-06